Drug intelligence / Profile preview

vaccinated donor plasma

Development stage
Unknown
Lead developer
Jiangsu Provincial People's Hospital
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Vaccinated donor plasma is a blood-derived therapeutic product consisting of plasma collected from individuals who have been vaccinated against SARS-CoV-2. This plasma contains high titers of vaccine-induced neutralizing antibodies and immunoglobulin G (IgG) specifically targeting the viral spike protein. It is used as a form of passive immunotherapy to provide immediate, though temporary, protection or treatment for COVID-19, particularly in immunocompromised patients or those at high risk of severe disease. Clinical evaluation, such as the study by Jiangsu Provincial People's Hospital (ChiCTR2300078690), focuses on the safety, durability of the immune response, and cost-effectiveness of this treatment compared to standard low-titer plasma.

Other names
vaccinee plasmavaccine-induced convalescent plasmaVax-CCPhigh-titer SARS-CoV-2 neutralizing antibody plasma
02

Targets

SARS-CoV-2 spike

Beyond the preview

Go deeper on vaccinated donor plasma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vaccinated donor plasma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call